| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI2
|
abl-interactor 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AIRE
|
autoimmune regulator
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANO7
|
anoctamin 7
|
|
ANXA1
|
annexin A1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARHGEF12
|
Rho guanine nucleotide exchange factor (GEF) 12
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAG1
|
BCL2-associated athanogene
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BNIP3
|
BCL2/adenovirus E1B 19kDa interacting protein 3
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRF1
|
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CASR
|
calcium-sensing receptor
|
|
CCND1
|
cyclin D1
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CHEK1
|
checkpoint kinase 1
|
|
COBL
|
cordon-bleu WH2 repeat protein
|
|
COL8A2
|
collagen, type VIII, alpha 2
|
|
COL9A1
|
collagen, type IX, alpha 1
|
|
CPD
|
carboxypeptidase D
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF2RA
|
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CTGF
|
connective tissue growth factor
|
|
CTSD
|
cathepsin D
|
|
CUL4A
|
cullin 4A
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DAXX
|
death-domain associated protein
|
|
DCK
|
deoxycytidine kinase
|
|
DDB1
|
damage-specific DNA binding protein 1, 127kDa
|
|
DPP3
|
dipeptidyl-peptidase 3
|
|
DYNLL1
|
dynein, light chain, LC8-type 1
|
|
EPO
|
erythropoietin
|
|
ESD
|
esterase D
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F10
|
coagulation factor X
|
|
F11
|
coagulation factor XI
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
FANCD2
|
Fanconi anemia, complementation group D2
|
|
FASN
|
fatty acid synthase
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa
|
|
FOXP3
|
forkhead box P3
|
|
FZD6
|
frizzled class receptor 6
|
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GCG
|
glucagon
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GLUD1
|
glutamate dehydrogenase 1
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HJURP
|
Holliday junction recognition protein
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI35
|
interferon-induced protein 35
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL2
|
interferon, lambda 2
|
|
IL10
|
interleukin 10
|
|
IL15
|
interleukin 15
|
|
IL19
|
interleukin 19
|
|
IL2
|
interleukin 2
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
JUN
|
jun proto-oncogene
|
|
KCNE2
|
potassium channel, voltage gated subfamily E regulatory beta subunit 2
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT15
|
keratin 15, type I
|
|
LAT2
|
linker for activation of T cells family, member 2
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LHCGR
|
luteinizing hormone/choriogonadotropin receptor
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LNPEP
|
leucyl/cystinyl aminopeptidase
|
|
LPAR5
|
lysophosphatidic acid receptor 5
|
|
LRBA
|
LPS-responsive vesicle trafficking, beach and anchor containing
|
|
LY96
|
lymphocyte antigen 96
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MATN3
|
matrilin 3
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MIF4GD
|
MIF4G domain containing
|
|
MIR143
|
microRNA 143
|
|
MIR27A
|
microRNA 27a
|
|
MIR329-1
|
microRNA 329-1
|
|
MIR410
|
microRNA 410
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSRB3
|
methionine sulfoxide reductase B3
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NBN
|
nibrin
|
|
NEU3
|
sialidase 3 (membrane sialidase)
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOX1
|
NADPH oxidase 1
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa
|
|
OCLN
|
occludin
|
|
OR2J3
|
olfactory receptor, family 2, subfamily J, member 3
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
PAH
|
phenylalanine hydroxylase
|
|
PARK7
|
parkinson protein 7
|
|
PAX6
|
paired box 6
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PHLDA1
|
pleckstrin homology-like domain, family A, member 1
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PKIB
|
protein kinase (cAMP-dependent, catalytic) inhibitor beta
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN13
|
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD1
|
RAD1 checkpoint DNA exonuclease
|
|
RASD1
|
RAS, dexamethasone-induced 1
|
|
RB1
|
retinoblastoma 1
|
|
RBX1
|
ring-box 1, E3 ubiquitin protein ligase
|
|
RCC2
|
regulator of chromosome condensation 2
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHOA
|
ras homolog family member A
|
|
RMRP
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINH1
|
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)
|
|
SGMS1
|
sphingomyelin synthase 1
|
|
SGMS2
|
sphingomyelin synthase 2
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SIRT1
|
sirtuin 1
|
|
SLC17A5
|
solute carrier family 17 (acidic sugar transporter), member 5
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC6A9
|
solute carrier family 6 (neurotransmitter transporter, glycine), member 9
|
|
SLURP1
|
secreted LY6/PLAUR domain containing 1
|
|
SMAD4
|
SMAD family member 4
|
|
SMN1
|
survival of motor neuron 1, telomeric
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOX6
|
SRY (sex determining region Y)-box 6
|
|
SP1
|
Sp1 transcription factor
|
|
SP3
|
Sp3 transcription factor
|
|
SPHK1
|
sphingosine kinase 1
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STC1
|
stanniocalcin 1
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
SULF2
|
sulfatase 2
|
|
SULT1E1
|
sulfotransferase family 1E, estrogen-preferring, member 1
|
|
TFAM
|
transcription factor A, mitochondrial
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR2
|
toll-like receptor 2
|
|
TLR5
|
toll-like receptor 5
|
|
TLR9
|
toll-like receptor 9
|
|
TNF
|
tumor necrosis factor
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TRIM11
|
tripartite motif containing 11
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRIM71
|
tripartite motif containing 71, E3 ubiquitin protein ligase
|
|
TRPC3
|
transient receptor potential cation channel, subfamily C, member 3
|
|
TRPM2
|
transient receptor potential cation channel, subfamily M, member 2
|
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
VANGL1
|
VANGL planar cell polarity protein 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VPRBP
|
Vpr (HIV-1) binding protein
|
|
VWF
|
von Willebrand factor
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
